Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pulmonary circulation

Showing results (521-530 of 1,725) with videos related to

Pageof 173
Sort By:
Pulmonary Circulation|July 22, 2022
Abnormal platelet aggregation in pediatric pulmonary hypertensionStephanie S Handler, Jing Jin, Michelle T Ogawa, et al.
Pulmonary Circulation|July 14, 2022
Pulmonary artery enlargement predicts poor survival in patients with COPD: A meta-analysisHuaqiao Chen, Tingting Shu, Lu Wang, et al.
Pulmonary Circulation|June 20, 2019
Oral treprostinil use in children: a multicenter, observational experienceUsama Kanaan, Nidhy P Varghese, Ryan D Coleman, et al.
Pulmonary Circulation|June 28, 2019
Chronic thromboembolic pulmonary hypertension following long-term peripherally inserted central venous catheter useAbigail Masding, Stephen D Preston, Mark Toshner, et al.
Pulmonary Circulation|February 14, 2022
Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizationsGautam Ramani, Steven Cassady, Eric Shen, et al.
Pulmonary Circulation|February 14, 2022
Transmembrane protein 16A/anoctamin 1 inhibitor T16A<sub>inh</sub>-A01 reversed monocrotaline-induced rat pulmonary arterial hypertensionJianye Xie, Wenyuan Liu, Wenjing Lv, et al.
Pulmonary Circulation|September 4, 2018
Compensated right ventricular function of the onset of pulmonary hypertension in a rat model depends on chamber remodeling and contractile augmentationDaniela Vélez-Rendón, Xiaoyan Zhang, Jesse Gerringer, et al.
Pulmonary Circulation|September 28, 2018
Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?Martin Koestenberger, Georg Hansmann
Pulmonary Circulation|September 4, 2025
Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational ModelMaria Niccum, Catherine M Avitabile, Dana Albizem, et al.
Pulmonary Circulation|September 5, 2025
How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension)Tilman Humpl, Rolf M F Berger, Damien Bonnet, et al.
Pageof 173

Showing results (521-530 of 1,725) with videos related to

Sort By:
Pageof 173
Pulmonary Circulation|July 22, 2022
Abnormal platelet aggregation in pediatric pulmonary hypertensionStephanie S Handler, Jing Jin, Michelle T Ogawa, et al.
Pulmonary Circulation|July 14, 2022
Pulmonary artery enlargement predicts poor survival in patients with COPD: A meta-analysisHuaqiao Chen, Tingting Shu, Lu Wang, et al.
Pulmonary Circulation|June 20, 2019
Oral treprostinil use in children: a multicenter, observational experienceUsama Kanaan, Nidhy P Varghese, Ryan D Coleman, et al.
Pulmonary Circulation|June 28, 2019
Chronic thromboembolic pulmonary hypertension following long-term peripherally inserted central venous catheter useAbigail Masding, Stephen D Preston, Mark Toshner, et al.
Pulmonary Circulation|February 14, 2022
Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizationsGautam Ramani, Steven Cassady, Eric Shen, et al.
Pulmonary Circulation|February 14, 2022
Transmembrane protein 16A/anoctamin 1 inhibitor T16A<sub>inh</sub>-A01 reversed monocrotaline-induced rat pulmonary arterial hypertensionJianye Xie, Wenyuan Liu, Wenjing Lv, et al.
Pulmonary Circulation|September 4, 2018
Compensated right ventricular function of the onset of pulmonary hypertension in a rat model depends on chamber remodeling and contractile augmentationDaniela Vélez-Rendón, Xiaoyan Zhang, Jesse Gerringer, et al.
Pulmonary Circulation|September 28, 2018
Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?Martin Koestenberger, Georg Hansmann
Pulmonary Circulation|September 4, 2025
Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational ModelMaria Niccum, Catherine M Avitabile, Dana Albizem, et al.
Pulmonary Circulation|September 5, 2025
How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension)Tilman Humpl, Rolf M F Berger, Damien Bonnet, et al.
Pageof 173